Drug application
OMTRYG (OMEGA-3-ACID ETHYL ESTERS TYPE A)
Drugs@FDA NDA 204977 · OSMOTICA PHARM US
Key facts
| Drug name | OMTRYG |
|---|---|
| Active ingredients | OMEGA-3-ACID ETHYL ESTERS TYPE A |
| Application type | NDA |
| Application number | 204977 |
| Company | OSMOTICA PHARM US |
| Dosage forms | CAPSULE, ORAL |
| Strength | 1.2GM CONTAINS AT LEAST 900MG OF THE ETHYL ESTERS OF OMEGA-3 FATTY ACIDS |
| Marketing status | Discontinued |
| Reference listed drug | Yes |
| Latest submission class | Type 5 - New Formulation or New Manufacturer |
| Latest submission status date | Apr 23, 2014 |
At a glance
- 1–9 Submissions
- 1–9 Supplements
- 1–9 Label versions
- 1–9 Products
- None Therapeutic equivalents
- Yes FDA letters on file
- Yes FDA reviews on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA · Source date: